{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:03:04Z","timestamp":1777006984725,"version":"3.51.4"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To provide an overview of the research hotspots and directions of type 3 macular neovascularization (MNV3) in age-related macular degeneration by bibliometric analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications related to MNV3 were retrieved from two databases, the Science Citation Index-Expanded database of the Web of Science Core Collection (WoSCC) and PubMed. CiteSpace was utilized to analyze country distribution, keyword bursts, and co-cited references. VOSviewer was employed to identify collaborative authors and the keyword co-occurrence network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 564 publications were identified from 2001 to 2026. They were performed in 97 countries, with the United States leading the way. Kim JW is the most prolific author, while Yannuzzi LA is the most cited author.\n                      <jats:italic>Investigative Ophthalmology &amp;amp; Visual Science<\/jats:italic>\n                      has published the most papers.\n                      <jats:italic>Retina-The Journal of Retinal and Vitreous Diseases<\/jats:italic>\n                      is the most cited journal. In the keyword co-occurrence network, apart from terms related to MNV3, \u201cranibizumab,\u201d \u201cphotodynamic therapy\u201d and \u201coptical coherence tomography\u201d are high-frequency keywords, while terms such as \u201cartificial intelligence,\u201d \u201cbiomarker,\u201d and \u201cmicroglia\u201d have emerged as more recent research hotspots. Research topics can be categorized into four major clusters: pathogenesis, imaging, therapy, clinical prognosis and long-term management. Meanwhile, highly cited co-cited articles successively addressed risk stratification, early identification, imaging evaluation, and standardized therapeutic regimens of MNV3, providing important references for clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This bibliometric analysis elucidates research hotspots and directions in MNV3 across pathophysiology, imaging, and therapy, and outlines the dynamic development of research in this field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1811978","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:32:08Z","timestamp":1777005128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global research trends and hotspots in the pathophysiology, imaging and therapy of type 3 macular neovascularization (MNV3) in age-related macular degeneration (AMD)"],"prefix":"10.3389","volume":"13","author":[{"given":"Ye","family":"Li","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Research Laboratory of Ophthalmology and Vision Sciences, Eye Research Institute, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Research Laboratory of Ophthalmology and Vision Sciences, Eye Research Institute, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Research Laboratory of Ophthalmology and Vision Sciences, Eye Research Institute, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Research Laboratory of Ophthalmology and Vision Sciences, Eye Research Institute, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Research Laboratory of Ophthalmology and Vision Sciences, Eye Research Institute, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration.","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","article-title":"Age-related macular degeneration and blindness due to neovascular maculopathy.","volume":"102","author":"Ferris","year":"1984","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","article-title":"Global burden of dry age-related macular degeneration: a targeted literature review.","volume":"43","author":"Schultz","year":"1960","journal-title":"Clin Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group.","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/bjo.2007.115501","article-title":"Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration.","volume":"91","author":"Cohen","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"769.e","DOI":"10.1016\/j.ajo.2014.07.006","article-title":"The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration.","volume":"158","author":"Jung","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/jcm4071380","article-title":"Long-term visual outcomes for a treat and extend anti-vascular endothelial growth factor regimen in eyes with neovascular age-related macular degeneration.","volume":"4","author":"Mrejen","year":"2015","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.oret.2025.01.011","article-title":"Macular atrophy in neovascular age-related macular degeneration: a systematic review and meta-analysis.","volume":"9","author":"Berni","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15252\/emmm.201505889","article-title":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.","volume":"8","author":"Regula","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development.","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1038\/s41598-021-88543-7","article-title":"Distinguishing retinal angiomatous proliferation from polypoidal choroidal vasculopathy with a deep neural network based on optical coherence tomography.","volume":"11","author":"Hwang","year":"2021","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s11192-014-1484-3","article-title":"Scientometrics and information retrieval: weak-links revitalized.","volume":"102","author":"Mayr","year":"2015","journal-title":"Scientometrics."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e21109","DOI":"10.1016\/j.heliyon.2023.e21109","article-title":"Hyperlipidemia and lipid-lowering therapy in diabetic retinopathy (DR): a bibliometric study and visualization analysis in 1993-2023.","volume":"9","author":"Tan","year":"2023","journal-title":"Heliyon."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1355397","DOI":"10.3389\/fcimb.2024.1355397","article-title":"Endophthalmitis: a bibliometric study and visualization analysis from 1993 to 2023.","volume":"14","author":"Fu","year":"2024","journal-title":"Front Cell Infect Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature.","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc Inf Sci Technol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"Silhouettes: a graphical aid to the interpretation and validation of cluster analysis.","volume":"20","author":"Rousseeuw","year":"1987","journal-title":"J Comput Appl Math."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1073\/pnas.0601602103","article-title":"Modularity and community structure in networks.","volume":"103","author":"Newman","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"26113","DOI":"10.1103\/PhysRevE.69.026113","article-title":"Finding and evaluating community structure in networks.","volume":"69","author":"Newman","year":"2004","journal-title":"Phys Rev E."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF00166756","article-title":"Classification of retinal pigment epithelial detachments associated with drusen.","volume":"230","author":"Hartnett","year":"1992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/s0161-6420(96)30389-8","article-title":"Deep retinal vascular anomalous complexes in advanced age-related macular degeneration.","volume":"103","author":"Hartnett","year":"2042","journal-title":"Ophthalmology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08820538.2019.1701045","article-title":"Results of switching from pro re nata to treat-and-extend regimen in treatment of patients with type 3 neovascularization.","volume":"35","author":"Kim","year":"2020","journal-title":"Semin Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000538441","article-title":"Effect of pro re nata regimen with anti-VEGF on type 3 macular neovascularization: long-term outcomes.","volume":"67","author":"Toto","year":"2024","journal-title":"Ophthalmic Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E270","DOI":"10.1111\/aos.14866","article-title":"The RAP study, report 3: discoloration of the macular region in patients with macular neovascularization type 3.","volume":"100","author":"Haj Najeeb","year":"2022","journal-title":"Acta Ophthalmol (Copenh.)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3390\/jcm12093049","article-title":"Prognostic optical coherence tomography biomarkers in neovascular age-related macular degeneration.","volume":"12","author":"Nawash","year":"2023","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajo.2024.02.018","article-title":"An automated comparative analysis of the exudative biomarkers in neovascular age-related macular degeneration, the RAP study: report 6.","volume":"264","author":"Haj Najeeb","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00417-022-05833-0","article-title":"Difference in characteristics and lesion reactivation between type 3 macular neovascularization with and without subretinal fluid at baseline.","volume":"261","author":"Kim","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.3390\/ijms23073443","article-title":"Transcriptional and distributional profiling of microglia in retinal angiomatous proliferation.","volume":"23","author":"Schlecht","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2023290118","DOI":"10.1073\/pnas.2023290118","article-title":"A specific RIP3+ subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism.","volume":"118","author":"He","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ymthe.2024.03.025","article-title":"SOCS3 regulates pathological retinal angiogenesis through modulating SPP1 expression in microglia and macrophages.","volume":"32","author":"Wang","year":"2024","journal-title":"Mol Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","article-title":"Retinal angiomatous proliferation in age-related macular degeneration.","volume":"21","author":"Yannuzzi","year":"2001","journal-title":"Retina"},{"key":"B33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.5301\/ejo.5000087","article-title":"Reproducibility of fluorescein and indocyanine green angiographic assessment for RAP diagnosis: a multicenter study.","volume":"22","author":"Parravano","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00417-014-2601-y","article-title":"Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.","volume":"252","author":"Yoneyama","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00417-017-3622-0","article-title":"Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration.","volume":"255","author":"Shijo","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000500203","article-title":"Intravitreal aflibercept for retinal angiomatous proliferation: results of a prospective case series at 96 weeks.","volume":"242","author":"Browning","year":"2019","journal-title":"Ophthalmologica"},{"key":"B37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/IAE.0b013e3181669504","article-title":"Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.","volume":"28","author":"Freund","year":"2008","journal-title":"Retina"},{"key":"B38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/IAE.0b013e3181619c55","article-title":"Review of retinal angiomatous proliferation or type 3 neovascularization.","volume":"28","author":"Yannuzzi","year":"2008","journal-title":"Retina."},{"key":"B39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00006982-200509000-00005","article-title":"Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation.","volume":"25","author":"Gross","year":"2005","journal-title":"Retina Phila Pa."},{"key":"B40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/s0161-6420(00)00009-9","article-title":"Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.","volume":"107","author":"Slakter","year":"2000","journal-title":"Ophthalmology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/00006982-200312000-00001","article-title":"Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis.","volume":"23","author":"Gass","year":"2003","journal-title":"Retina."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1001\/archopht.123.12.1644","article-title":"Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.","volume":"123","author":"Bottoni","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.1995.01100110052025","article-title":"Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments.","volume":"113","author":"Kuhn","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/IAE.0000000000000488","article-title":"Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.","volume":"35","author":"Nagiel","year":"2015","journal-title":"Retina"},{"key":"B45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/IAE.0000000000003330","article-title":"The RAP study, report 5: rediscovering macular neovascularization type 3: multimodal imaging of fellow eyes over 24 months.","volume":"42","author":"Haj Najeeb","year":"2022","journal-title":"Retina"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/IAE.0000000000002774","article-title":"The RAP study, report two: the regional distribution of macular neovascularization type 3, a novel insight into its etiology.","volume":"40","author":"Haj Najeeb","year":"2020","journal-title":"Retina Phila Pa."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/IAE.0000000000002489","article-title":"Characteristics of type 3 neovascularization lesions: focus on the incidence of multifocal lesions and the distribution of lesion location.","volume":"40","author":"Kim","year":"2020","journal-title":"Retina Phila Pa."},{"key":"B48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/bjophthalmol-2019-315311","article-title":"RAP study, report 1: novel subtype of macular neovascularisation type III.","volume":"105","author":"Haj Najeeb","year":"2020","journal-title":"Br J Ophthalmol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.xops.2023.100280","article-title":"Histology of type 3 macular neovascularization and microvascular anomalies in treated age-related macular degeneration: a case study.","volume":"3","author":"Berlin","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1097\/IAE.0000000000002412","article-title":"New proposal for the pathophysiology of type 3 neovascularization as based on multimodal imaging findings.","volume":"39","author":"Spaide","year":"2019","journal-title":"Retina"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1097\/IAE.0000000000002198","article-title":"Reduced choriocapillaris flow in eyes with type 3 neovascularization and age-related macular degeneration.","volume":"38","author":"Borrelli","year":"1968","journal-title":"Retina"},{"key":"B52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ophtha.2015.10.034","article-title":"Outcomes in eyes with retinal angiomatous proliferation in the comparison of age-related macular degeneration treatments trials (CATT).","volume":"123","author":"Daniel","year":"2016","journal-title":"Ophthalmology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"285.e","DOI":"10.1016\/j.ajo.2014.10.035","article-title":"Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation.","volume":"159","author":"Cho","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.65.3.18","article-title":"Distinct pathways of macular atrophy in type 3 macular neovascularization associated with AMD.","volume":"65","author":"Borrelli","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/IAE.0b013e3181fe54c7","article-title":"Geographic atrophy in retinal angiomatous proliferation.","volume":"31","author":"McBain","year":"2011","journal-title":"Retina"},{"key":"B57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00417-015-2993-3","article-title":"Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.","volume":"254","author":"Cho","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1097\/IAE.0000000000001104","article-title":"Treat-and-extend regimen with aflibercept for retinal angiomatous proliferation.","volume":"36","author":"Matsumoto","year":"2016","journal-title":"Retina"},{"key":"B59","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.iae.0000434566.57189.37","article-title":"Incidence and characteristics of neovascularization in fellow eyes of Japanese patients with unilateral retinal angiomatous proliferation.","volume":"34","author":"Sawa","year":"2014","journal-title":"Retina."},{"key":"B60","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1111\/aos.12748","article-title":"Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population.","volume":"94","author":"Chang","year":"2016","journal-title":"Acta Ophthalmol (Copenh.)."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/IAE.0b013e31827b639e","article-title":"Precursors of type 3 neovascularization: a multimodal imaging analysis.","volume":"33","author":"Querques","year":"2013","journal-title":"Retina"},{"key":"B62","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcjo.2021.04.020","article-title":"Longitudinal assessment of type 3 macular neovascularization using 3D volume-rendering OCTA.","volume":"57","author":"Borrelli","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","article-title":"Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration.","volume":"40","author":"Teo","year":"2020","journal-title":"Retina"},{"key":"B64","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/eye.2015.27","article-title":"En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation).","volume":"29","author":"Dansingani","year":"2015","journal-title":"Eye."},{"key":"B65","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/IAE.0000000000001343","article-title":"Type 3 neovascularization imaged with cross-sectional and en face optical coherence tomography angiography.","volume":"37","author":"Tan","year":"2017","journal-title":"Retina."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/IAE.0000000000000835","article-title":"Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration.","volume":"35","author":"Kuehlewein","year":"2015","journal-title":"Retina"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/IAE.0000000000001447","article-title":"Optical coherence tomography angiography changes in early type 3 neovascularization after anti-vascular endothelial growth factor treatment.","volume":"37","author":"Miere","year":"2017","journal-title":"Retina"},{"key":"B68","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1038\/s41598-019-53307-x","article-title":"Rotational three-dimensional OCTA: a notable new imaging tool to characterize type 3 macular neovascularization.","volume":"9","author":"Borrelli","year":"2019","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ajo.2012.11.001","article-title":"Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.","volume":"155","author":"Kim","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/IAE.0000000000000086","article-title":"Subfoveal choroidal thickness in retinal angiomatous proliferation.","volume":"34","author":"Yamazaki","year":"2014","journal-title":"Retina."},{"key":"B71","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/IAE.0000000000000486","article-title":"Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.","volume":"35","author":"Maruko","year":"2015","journal-title":"Retina"},{"key":"B72","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/archopht.121.4.558","article-title":"Surgical ablation of retinal angiomatous proliferation.","volume":"121","author":"Borrillo","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/01.iae.0000224938.61915.f0","article-title":"Recurrence after surgical ablation for retinal angiomatous proliferation.","volume":"27","author":"Shiragami","year":"2007","journal-title":"Retina"},{"key":"B74","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ajo.2005.12.029","article-title":"Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation.","volume":"141","author":"Nakata","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/IAE.0b013e3180ed45a6","article-title":"Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.","volume":"27","author":"Roth","year":"2007","journal-title":"Retina"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/bjo.2006.092536","article-title":"Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.","volume":"90","author":"Krieglstein","year":"2006","journal-title":"Br J Ophthalmol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/bjo.2007.122119","article-title":"Combined therapy for retinal angiomatous proliferation with intravitreal triamcinolone and argon laser photocoagulation.","volume":"92","author":"Mendis","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archopht.124.4.487","article-title":"Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.","volume":"124","author":"Freund","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajo.2006.10.045","article-title":"Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.","volume":"143","author":"Van De Moere","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/IAE.0b013e3181a0be1d","article-title":"Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.","volume":"29","author":"Gharbiya","year":"2009","journal-title":"Retina"},{"key":"B81","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12886-015-0172-2","article-title":"One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages.","volume":"15","author":"Park","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1141077","DOI":"10.3389\/fphar.2023.1141077","article-title":"Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis.","volume":"14","author":"Fallico","year":"2023","journal-title":"Front Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10384-015-0417-x","article-title":"Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.","volume":"60","author":"Saito","year":"2016","journal-title":"Jpn J Ophthalmol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1097\/IAE.0000000000000225","article-title":"Optical coherence tomography\u2013based ranibizumab monotherapy for retinal angiomatous proliferation in Korean patients.","volume":"34","author":"Shin","year":"2014","journal-title":"Retina."},{"key":"B85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000487610","article-title":"Long-term results of combination treatment with single-dose ranibizumab plus photodynamic therapy for retinal angiomatous proliferation.","volume":"240","author":"Malamos","year":"2018","journal-title":"Ophthalmologica"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/IAE.0b013e318235d8ce","article-title":"Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation.","volume":"32","author":"Rouvas","year":"2012","journal-title":"Retina"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00417-020-05028-5","article-title":"Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.","volume":"259","author":"Lee","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.66.12.37","article-title":"Reshaping the burden of nAMD: national, regional, and global prevalence of MNV3 and its correlation with life expectancy-the RAP study, report 7.","volume":"66","author":"Haj Najeeb","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12886-020-01561-3","article-title":"Predictors of health-related quality of life in Chinese patients receiving treatment for neovascular age-related macular degeneration: a prospective longitudinal study.","volume":"20","author":"Bian","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.survophthal.2023.09.001","article-title":"Barriers to care in neovascular age-related macular degeneration: current understanding, developments, and future directions.","volume":"69","author":"Choi","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1097\/IAE.0000000000000932","article-title":"Diagnosis of type 3 neovascularization based on optical coherence tomography images.","volume":"36","author":"Kim","year":"2016","journal-title":"Retina Phila Pa."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1097\/IAE.0000000000001862","article-title":"Intravitreal aflibercept and ranibizumab injections for type 3 neovascularization.","volume":"38","author":"Cho","year":"2018","journal-title":"Retina"},{"key":"B93","doi-asserted-by":"publisher","first-page":"22546","DOI":"10.1038\/s41598-022-25860-5","article-title":"Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization.","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ajo.2015.07.023","article-title":"Retinal pigment epithelial tear after intravitreal ranibizumab treatment for retinal angiomatous proliferation.","volume":"160","author":"Cho","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1080\/08820538.2018.1511814","article-title":"Early recurrent hemorrhage in submacular hemorrhage secondary to type 3 neovascularization or retinal angiomatous proliferation: incidence and influence on visual prognosis.","volume":"33","author":"Kim","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00417-021-05163-7","article-title":"Assessing the long-term evolution of type 3 neovascularization in age-related macular degeneration using optical coherence tomography angiography.","volume":"259","author":"Cho","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/IAE.0000000000003797","article-title":"Incidence and timing of pigment epithelial detachment and subretinal fluid development in type 3 macular neovascularization associated with age-related macular degeneration.","volume":"43","author":"Kim","year":"2023","journal-title":"Retina."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0310097","DOI":"10.1371\/journal.pone.0310097","article-title":"Prediction of fellow eye neovascularization in type 3 macular neovascularization (Retinal angiomatous proliferation) using deep learning.","volume":"19","author":"Yoon","year":"2024","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12886-024-03613-4","article-title":"Importance of optical coherence tomography raster scans in early detection of active fellow-eye neovascularization in unilateral neovascular age-related macular degeneration.","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Ophthalmol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","article-title":"An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography.","volume":"36","author":"Su","year":"2016","journal-title":"Retina"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1097\/IAE.0b013e3181bfbd46","article-title":"\u2018Treat and extend\u2019 dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization\/retinal angiomatous proliferation.","volume":"29","author":"Engelbert","year":"2009","journal-title":"Retina Phila Pa."},{"key":"B102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-319-75402-4_22","article-title":"The role of hypoxia, hypoxia-inducible factor (HIF), and VEGF in retinal angiomatous proliferation.","volume-title":"Retinal Degenerative Diseases.","author":"Barben","year":"2018"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/s41433-024-03034-z","article-title":"The potential key role of choroidal non-perfusion and rod degeneration in the pathogenesis of macular neovascularization type 3.","volume":"38","author":"Haj Najeeb","year":"2024","journal-title":"Eye."},{"key":"B104","doi-asserted-by":"publisher","first-page":"734860","DOI":"10.3389\/fnins.2021.734860","article-title":"Clinical pathological features and current animal models of type 3 macular neovascularization.","volume":"15","author":"Qiang","year":"2021","journal-title":"Front Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e127889","DOI":"10.1172\/jci.insight.127889","article-title":"Rb1\/Rbl1\/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma.","volume":"4","author":"Wei","year":"2018","journal-title":"JCI Insight"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s10792-016-0413-2","article-title":"Association of ARMS2\/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.","volume":"37","author":"Bonyadi","year":"2017","journal-title":"Int Ophthalmol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1167\/iovs.10-5554","article-title":"CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.","volume":"51","author":"Hayashi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","article-title":"The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.","volume":"18","author":"Tortajada","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B109","first-page":"6046","article-title":"Mutations in CFH perturb RPE homeostasis in vitro.","volume":"57","author":"Hazim","year":"2016","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/archopht.125.6.795","article-title":"Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.","volume":"125","author":"Li","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mvr.2009.02.005","article-title":"Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency.","volume":"78","author":"Chen","year":"2009","journal-title":"Microvasc Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3928\/23258160-20200228-02","article-title":"Evaluating retinal angiomatous proliferation with optical coherence tomography angiography.","volume":"51","author":"Mao","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"B113","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40135-018-0158-3","article-title":"Swept source optical coherence tomography: a review.","volume":"6","author":"Yasin Alibhai","year":"2018","journal-title":"Curr Ophthalmol Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/biomedicines10030694","article-title":"Vascular analysis of type 1, 2, and 3 macular neovascularization in age-related macular degeneration using swept-source optical coherence tomography angiography shows new insights into differences of pathologic vasculature and may lead to a more personalized understanding.","volume":"10","author":"Faatz","year":"2022","journal-title":"Biomedicines"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1044.e","DOI":"10.1016\/j.ajo.2015.07.026","article-title":"Phase-resolved doppler optical coherence tomographic features in retinal angiomatous proliferation.","volume":"160","author":"Amarakoon","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00417-021-05332-8","article-title":"The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3.","volume":"260","author":"Haj Najeeb","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/genes14071438","article-title":"Retinal angiomatous proliferation in a patient with retinitis pigmentosa.","volume":"14","author":"Kiraly","year":"2023","journal-title":"Genes."},{"key":"B118","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1600-0420.2007.01087.x","article-title":"Subretinal surgery and transplantation of autologous pigment epithelial cells in retinal angiomatous proliferation.","volume":"86","author":"Krebs","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.ophtha.2015.06.053","article-title":"Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study.","volume":"122","author":"Kuroda","year":"2015","journal-title":"Ophthalmology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/bjophthalmol-2015-307299","article-title":"Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration.","volume":"100","author":"Hatz","year":"2016","journal-title":"Br J Ophthalmol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00417-019-04306-1","article-title":"Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment.","volume":"257","author":"Kim","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1167\/iovs.15-18837","article-title":"Geographic atrophy and activity of neovascularization in retinal angiomatous proliferation.","volume":"57","author":"Baek","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00417-019-04373-4","article-title":"Focal retinal pigment epithelium atrophy at the location of type 3.","volume":"257","author":"Kim","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1811978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:32:14Z","timestamp":1777005134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1811978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":123,"alternative-id":["10.3389\/fmed.2026.1811978"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1811978","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1811978"}}